GondolaBio researches, develops and manufactures pharmaceutical products.
GondolaBio has raised $300.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in August 2024.
GondolaBio's investors include Sequoia Capital, Cormorant Asset Management, Patient Square Capital, Frazier Life Sciences, Aisling Capital.
GondolaBio is headquartered in Palo Alto, United States.
GondolaBio researches, develops and manufactures pharmaceutical products.
GondolaBio is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"GondolaBio — Funding & Investors." VCBacked, August 16, 2024, https://www.vcbacked.co/company/gondolabio. Accessed July 19, 2026.
VCBacked. (2024). GondolaBio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/gondolabio
{{cite web |title=GondolaBio — Funding & Investors |url=https://www.vcbacked.co/company/gondolabio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated